跳至主要内容
临床试验/NCT03788733
NCT03788733Unknown不适用

Study of the Efficacy of Melatonin in the Burning Mouth Syndrome

Universidad de Murcia1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年12月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Sleep Questionnaire

研究概览

简要总结

Burning mouth ( BMS) syndrome is the oral disorder characterized by an intraoral burning sensation for which no medical or dental cause can be found. The Headache Classification Committee of the International Headache Society (IHS) defines (BMS) as an ''intraoral burning or dysaesthetic sensation, recurring daily for more than 2 hours per day over more than 3 months, without clinically evident causative lesions''. (BMS) is a common, chronic problem that has a negative impact on quality of life.

A wide variety of medications have been proposed for treating (BMS) both topical and systemic. Unfortunately, no treatment seems to offer assured results. Melatonin is a naturally occurring hormone secreted by the pineal gland. It has soporific effects with oral administration and is well tolerated. It enhances sleep Melatonin also may help sleep disturbances associated with (BMS) ; however, this remains to be proven.

详细描述

The purpose of this study is to establish whether melatonin can aid in reducing pain improve sleep quality in (BMS)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Intraoral burning or dysaesthetic sensation, recurring daily for more than 2 hours per day over more than 3 months, without clinically evident causative lesions

排除标准

  • Previous or current therapy with melatonin
  • Allergy or hypersensitivity to melatonin
  • Less than 18 years old.

研究组 & 干预措施

Melatonin

Experimental

Melatonin ORAL FILM 3mg will be taken by the subject once a day for 8 weeks

干预措施: Melatonin 3 mg (Drug)

placebo

Placebo Comparator

ORAL FILM 3mg placebo will be taken by the subject once a day for 8 weeks

干预措施: Placebo Oral (Drug)

结局指标

主要结局

Sleep Questionnaire

时间窗: 8 weeks.The PSQI total score ranges from 0 to 21 with 0 being marvelous sleep and 21 being horrid sleep. The difference score, reported below, is the total score after at least 8 weeks of treatment. A negative score means that the sleep

The Pittsburgh Sleep Quality Index (PSQI)

次要结局

  • Oral Pain(8 weeks.Pain was scored using a Visual Analogue Scale (VAS) (with a score of 1-10: 0 = no pain, 10 = extreme pain))
  • Questionnaire ORAL Quality of life(8 weeks The instrument consists of 14 items that explore different aspects of oral function and quality of life. The score ranges from 0 to 70, with higher scores corresponding to poorer oral quality of life.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pia Lopez Jornet

Head of Oral Medicine

Universidad de Murcia

研究点 (1)

Loading locations...

相似试验